8.03
7.91%
-0.69
アフターアワーズ:
7.77
-0.26
-3.24%
Annovis Bio Inc (ANVS) 最新ニュース
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc ... - Business Wire
Business Wire
Annovis Bio Inc put volume heavy and directionally bearish - TipRanks.com - TipRanks
TipRanks
The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors - Business Wire
Business Wire
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks Investment Research
HC Wainwright Analysts Raise Earnings Estimates for Annovis Bio, Inc. (NYSE:ANVS) - Defense World
Defense World
HC Wainwright Analysts Raise Earnings Estimates for Annovis Bio, Inc. (NYSE:ANVS) - Defense World
Defense World
Behind the Scenes of Annovis Bio's Latest Options Trends - Annovis Bio (NYSE:ANVS) - Benzinga
Benzinga
HC Wainwright Analysts Boost Earnings Estimates for Annovis Bio, Inc. (NYSE:ANVS) - MarketBeat
MarketBeat
Annovis Bio reports Q1 EPS (72c), consensus (80c) - TipRanks.com - TipRanks
TipRanks
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Zacks Investment Research
Annovis Bio (NYSE:ANVS) Price Target Cut to $23.00 by Analysts at HC Wainwright - MarketBeat
MarketBeat
Largest borrow rate increases among liquid names - TipRanks.com - TipRanks
TipRanks
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results - GlobeNewswire
GlobeNewswire
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results - Yahoo Finance
Yahoo Finance
Annovis Bio Inc put volume heavy and directionally bearish - TipRanks.com - TipRanks
TipRanks
Is Annovis Bio (ANVS) Stock Outpacing Its Medical Peers This Year? - Yahoo Movies Canada
Yahoo Movies Canada
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
Zacks Investment Research
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
Zacks Investment Research
Annovis Bio stock gains on plans for Parkinson's readout - Seeking Alpha
Seeking Alpha
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks Investment Research
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's Disease - Yahoo Finance
Yahoo Finance
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
Zacks Investment Research
Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
Zacks Investment Research
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
Zacks Investment Research
Wall Street Analysts See a 213.78% Upside in Annovis Bio, Inc. (ANVS): Can the Stock Really Move This High? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks Investment Research
Annovis (ANVS) Gains on FDA Authorization for AD Study - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Annovis Bio, Inc. (ANVS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Annovis Bio Issues Key Update on Corporate Progress - TipRanks.com - TipRanks
TipRanks
Annovis Bio refines Alzheimer's trial approach after Phase II/III data - Investing.com Nigeria
Investing.com Nigeria
Annovis Bio refines Alzheimer's trial approach after Phase II/III data - Investing.com
Investing.com
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
GlobeNewswire Inc.
Annovis Bio Issues Key Update on Corporate Progress - TipRanks.com - TipRanks
TipRanks
Annovis Bio (NYSE:ANVS) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Zacks Investment Research
Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market (NYSE:ANVS) - Seeking Alpha
Seeking Alpha
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects (NYSE:ANVS) - Seeking Alpha
Seeking Alpha
Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
Zacks Investment Research
Annovis: Alzheimer's Phase 2/3 Topline Readout Puts Buntanetap Future Into Question (ANVS) - Seeking Alpha
Seeking Alpha
Annovis battles stock slide, heads for a phase III in Alzheimer's - BioWorld Online
BioWorld Online
Annovis Bio Target of Unusually Large Options Trading (NYSE:ANVS) - MarketBeat
MarketBeat
Annovis Bio reports cognitive gains in Alzheimer's study - Investing.com
Investing.com
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
GlobeNewswire Inc.
Annovis Bio plunges on mid-stage data from Alzheimer's treatment - XM
XM
Wall Street Breakfast: The Week Ahead
Seeking Alpha
FOMC Meeting, Jobs Report, And Apple Earnings Headline Big Week
Seeking Alpha
Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade
Zacks Investment Research
Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade - Yahoo Finance
Yahoo Finance
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):